Results 51 to 60 of about 12,843 (159)

Vitiligo Vitiligo

open access: yesAnais Brasileiros de Dermatologia, 2004
O vitiligo é doença de pele de causa desconhecida que acomete cerca de 1% da população, comprometendo de modo semelhante homens e mulheres, preferencialmente entre 10 e 30 anos de idade.
Denise Steiner   +4 more
doaj   +1 more source

Epidermal necrolysis sequelae: A cohort study on prevalence and risk factors

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Long‐term sequelae after epidermal necrolysis are frequent, multiple and often severe. Cutaneous, ocular and psychological complications are more frequent, with significant socioeconomic impact. Cluster analysis identifies distinct patient profiles, highlighting the need for personalized multidisciplinary follow‐up.
Thanh Vy Nguyen   +9 more
wiley   +1 more source

Extensive Extragenital Lichen Sclerosus-Like Lesions in a Patient with Junctional Epidermolysis Bullosa

open access: yesIndian Dermatology Online Journal
Epidermolysis bullosa (EB) is a heterogeneous group of genetic disorders characterized by the formation of blisters either spontaneously or at the sites of trauma. These heal with post-inflammatory hypopigmentation, scarring, or milia formation.
Smriti Gupta   +4 more
doaj   +1 more source

Human Skin Lightening Efficacy of Resveratrol and Its Analogs: From in Vitro Studies to Cosmetic Applications

open access: yesAntioxidants, 2019
Antioxidants are deemed useful in controlling oxidative stress associated with extrinsic skin aging and pigmentation disorders. Resveratrol is a polyphenol compound found in many edible plants such as Vitis vinifera, and its inhibitory effects on the ...
Yong Chool Boo
doaj   +1 more source

Consensus on energy‐based devices for keloids and hypertrophic scars: A Latin American Delphi study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Latin American Delphi consensus supports a sequential, multimodal approach to keloids and hypertrophic scars: vascular devices for early/inflammatory lesions; intralesional triamcinolone + 5‐fluorouracil and other injectable drugs for active scars; fractional lasers for texture; and pigment‐targeting therapies for dyschromia, prioritizing safety in ...
Gisele Viana de Oliveira   +24 more
wiley   +1 more source

Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT

open access: yesHealth Technology Assessment, 2020
Background: Systematic reviews suggest that narrowband ultraviolet B light combined with treatments such as topical corticosteroids may be more effective than monotherapy for vitiligo.
Jonathan M Batchelor   +34 more
doaj   +1 more source

Male genital lichen sclerosus

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Male genital lichen sclerosus is driven by chronic, occluded exposure of susceptible genital epithelium to urine, rather than infection or autoimmunity. This review synthesizes clinical, anatomical and molecular evidence showing how microincontinence and occlusion initiate inflammation, fibrosis and carcinogenesis, and explains the curative effect of ...
Georgios Kravvas   +3 more
wiley   +1 more source

Expanding the Clinical Spectrum of DHX30‐Related Neurodevelopmental Disorder: A Case Report and a Scoping Review

open access: yesJournal of Intellectual Disability Research, EarlyView.
ABSTRACT Background Whole exome sequencing (WES) has improved diagnostic rates for neurodevelopmental disorders (NDDs) while introducing challenges in novel variant interpretation. DHX30‐related NDD (DHX30‐NDD) is a recently described condition with an evolving phenotypic spectrum.
Nattaporn Tassanakijpanich   +3 more
wiley   +1 more source

Regional Nerve Blocks and OnabotulinumtoxinA in the Management of Trigeminal Trophic Syndrome: A Case Report of a Novel Multimodal Approach

open access: yesOral Surgery, EarlyView.
ABSTRACT Objective Trigeminal trophic syndrome (TTS) is a rare condition caused by trigeminal nerve injury, classically characterized by anaesthesia, paresthesia and facial ulceration. We present two cases of TTS successfully managed with regional nerve blocks and onabotulinumtoxinA. Methods Two patients—a 54‐year‐old woman and a 65‐year‐old man—with a
Shamin Masrour, Rhea Sudhakaran
wiley   +1 more source

Afecciones dermatológicas con hipopigmentación en un área de salud. Mayo-diciembre, 2010</a> </p><span class="r_subtitle"><img src="/img/openaccess.ico" alt="open access: yes" title="open access: yes" width="16" height="16"><i>Revista Médica Electrónica</i>, 2011 </span><br><span class="r_content">Las afecciones cutáneas con hipopigmentación constituyen una causa frecuente de consulta en el mundo y en, ya que es un síntoma común a numerosas enfermedades dermatológicas, pero hasta el momento, a pesar de la revisión bibliográfica realizada, se ha ...</span><br><span class="r_sub"><i>Tamara M Pérez Martell<span id="ma_10" style="display:none">, Isahiris González García</span>   <small><a href="#" style="color:#808080;" onClick="return toggle_div(this, 'ma_10')">+1 more</a></small></i></span><br><small><a href="https://doaj.org/article/7cfd28254f3a455da8ca264857755269" target="_blank" rel="nofollow" title="doaj.org/article/7cfd28254f3a455da8ca264857755269">doaj</a> </small>   <br></div><div class="r"><div style="margin-bottom:2px;overflow:hidden"><div style="display: inline-block; float: left; font-size: small; padding-right: 16px; margin-top: -1px; padding-bottom: 1px;"><a href="/q-hyperpigmentation/" class="suggestion"onclick="show_loader();"><b>hyperpigmentation</b></a><br/><a href="/q-vitiligo/" class="suggestion"onclick="show_loader();"><b>vitiligo</b></a><br/><a href="/q-melanocytes/" class="suggestion"onclick="show_loader();"><b>melanocytes</b></a><br/></div><div style="display: inline-block; float: left; font-size: small; padding-right: 16px; margin-top: -1px; padding-bottom: 1px;"></div></div></div><div class="pagenav"><a href="/q-hypopigmentation/p-5/" rel="nofollow"><b>previous</b></a>   <a href="/q-hypopigmentation/p-4/" rel="nofollow">4</a>  <a href="/q-hypopigmentation/p-5/" rel="nofollow">5</a>  <b>6</b>  <a href="/q-hypopigmentation/p-7/" rel="nofollow">7</a>  <a href="/q-hypopigmentation/p-8/" rel="nofollow">8</a>   <a href="/q-hypopigmentation/p-7/" id="next" rel="nofollow"><b>next</b></a> </div><br></div> </div> <script>document.getElementById('loadingGif').style.display='none';</script><div style="width: 100%; height: 40px; bottom: 0px; background-color: #f5f5f5;"><div style="padding-left: 15px; padding-top: 10px"> <a href="/" rel="nofollow">Home</a> - <a href="/page-about/" rel="nofollow">About</a> - <a href="/page-disclaimer/" rel="nofollow">Disclaimer</a> - <a href="/page-privacy/" rel="nofollow">Privacy</a> </div></div> <link rel="stylesheet" href="//ajax.googleapis.com/ajax/libs/jqueryui/1.11.4/themes/smoothness/jquery-ui.min.css"/> <script> (function(ss,ex){ window.ldfdr=window.ldfdr||function(){(ldfdr._q=ldfdr._q||[]).push([].slice.call(arguments));}; (function(d,s){ fs=d.getElementsByTagName(s)[0]; function ce(src){ var cs=d.createElement(s); cs.src=src; cs.async=1; fs.parentNode.insertBefore(cs,fs); }; ce('https://sc.lfeeder.com/lftracker_v1_'+ss+(ex?'_'+ex:'')+'.js'); })(document,'script'); })('JMvZ8gvrWA9a2pOd'); </script> </body> </html>